Analyst Price Targets — LINE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 1, 2026 10:30 am | — | Wells Fargo | $38.00 | $39.25 | TheFly | Lineage price target raised to $38 from $36 at Wells Fargo |
| August 27, 2026 10:37 am | — | Piper Sandler | $44.00 | $40.56 | TheFly | Lineage price target lowered to $44 from $46 at Piper Sandler |
| August 17, 2026 11:32 am | Michael Carroll | RBC Capital | $48.00 | $41.75 | TheFly | Lineage price target raised to $48 from $44 at RBC Capital |
| August 12, 2026 9:25 pm | — | Goldman Sachs | $53.00 | $41.50 | TheFly | Lineage price target lowered to $53 from $54 at Goldman Sachs |
| August 6, 2026 1:38 pm | — | Robert W. Baird | $43.00 | $42.38 | TheFly | Lineage price target raised to $43 from $40 at Baird |
| July 28, 2026 11:57 pm | — | Mizuho Securities | $47.00 | $42.61 | TheFly | Lineage upgraded to Outperform from Neutral at Mizuho |
| July 21, 2026 11:03 am | — | Piper Sandler | $46.00 | $43.22 | TheFly | Lineage price target raised to $46 from $35 at Piper Sandler |
| July 17, 2026 11:40 am | — | UBS | $45.00 | $44.27 | TheFly | Lineage price target raised to $45 from $35 at UBS |
| June 18, 2026 11:52 am | — | Scotiabank | $45.00 | $41.53 | TheFly | Lineage price target raised to $45 from $42 at Scotiabank |
| June 17, 2026 11:42 am | Michael Lewis | Truist Financial | $46.00 | $42.83 | TheFly | Lineage price target raised to $46 from $44 at Truist |
Latest News for LINE
New Program Introduces Flexible Rewards, Status Recognition, Milestone Benefits and More Ways for Guests to Unlock Meaningful Value MIAMI, Sept. 1, 2026 /PRNewswire/ -- Carnival Cruise Line launched Carnival Rewards today, a first-of-its-kind loyalty program in the cruise industry that gives guests more ways to earn rewards, achieve status and be recognized in ways that matter most to them.
BlackRock Inc. bought a new position in shares of Lineage, Inc. (NASDAQ: LINE) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,260,370 shares of the company's stock, valued at approximately $227,511,000. BlackRock Inc. owned 2.31% of Lineage as of its most recent
BOCA RATON, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- KARMAN LINE ACQUISITION CORP. (the “Company”), a special purpose acquisition company, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed for trading on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “XTERU” beginning August 18, 2026. Each unit consists of one…
Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline during its second-quarter 2026 earnings call, highlighting preclinical advances in corneal disease, Type 1 diabetes and hearing loss programs while Roche and Genentech continue surgical-delivery optimization work for its lead OpRegen program.
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.